We are live on ! Find out more
XERS icon

Xeris Biopharma Holdings
XERS

30 hedge funds and large institutions have $184M invested in Xeris Biopharma Holdings in 2018 Q2 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

48.45% more ownership

Funds ownership: 0% → 48.45% (+48%)

Holders
30
Holders Change
+30
Holders Change %
–
% of All Funds
0.69%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
30
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$48.6M
2
RG
Redmile Group
California
+$46.9M
3
O
OppenheimerFunds
New York
+$19.4M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.6M
5
ACH
ArrowMark Colorado Holdings
Colorado
+$11.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$47.4M +$48.6M +2,498,666 New
RG
2
Redmile Group
California
$45.8M +$46.9M +2,412,642 New
O
3
OppenheimerFunds
New York
$19M +$19.4M +1,000,000 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$15.2M +$15.6M +801,800 New
ACH
5
ArrowMark Colorado Holdings
Colorado
$11.3M +$11.6M +595,202 New
PA
6
Perceptive Advisors
New York
$8.54M +$8.74M +450,000 New
SM
7
Sabby Management
Florida
$8.5M +$8.7M +447,686 New
Federated Hermes
8
Federated Hermes
Pennsylvania
$5.69M +$5.83M +300,000 New
BC
9
Broadfin Capital
New York
$4.75M +$4.86M +250,000 New
FCM
10
Farallon Capital Management
California
$3.03M +$3.1M +159,500 New
MIM
11
Monashee Investment Management
Massachusetts
$2.94M – – –
GIM
12
Granahan Investment Management
Massachusetts
$2.48M +$2.54M +130,700 New
Neuberger Berman Group
13
Neuberger Berman Group
New York
$2.18M +$2.23M +115,000 New
Millennium Management
14
Millennium Management
New York
$1.9M +$1.94M +100,000 New
LCM
15
Landscape Capital Management
New Jersey
$1.08M +$1.11M +57,045 New
MWNA
16
Marshall Wace North America
New York
$783K +$802K +41,266 New
Wellington Management Group
17
Wellington Management Group
Massachusetts
$633K +$648K +33,333 New
DIM
18
DC Investments Management
Virginia
$563K +$577K +29,674 New
Goldman Sachs
19
Goldman Sachs
New York
$541K +$554K +28,500 New
BlackRock
20
BlackRock
New York
$475K +$486K +25,000 New
Vanguard Group
21
Vanguard Group
Pennsylvania
$474K +$486K +25,000 New
PPA
22
Parametric Portfolio Associates
Washington
$412K +$422K +21,700 New
Norges Bank
23
Norges Bank
Norway
$285K +$291K +15,000 New
Citadel Advisors
24
Citadel Advisors
Florida
$214K +$219K +11,290 New
Point72 Asset Management
25
Point72 Asset Management
Connecticut
$95K +$97.2K +5,000 New
1
2

XERS Hedge Fund Activity: Q2 2018 in Review

30 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Xeris Biopharma Holdings (XERS) for Q2 2018, worth a combined $184M.

Buyers outnumbered sellers: 30 funds opened new XERS positions and 0 closed out — a net gain of 30 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $48.6M.

  • 30 institutional investors held Xeris Biopharma Holdings (XERS) as of Q2 2018, up from 0 in Q1 2018.
  • Funds reported $184M of Xeris Biopharma Holdings stock for Q2 2018.
  • 30 funds opened new Xeris Biopharma Holdings positions in Q2 2018 and 0 closed out, a net change of +30 holders.
  • The largest Xeris Biopharma Holdings buyer in Q2 2018 was Deerfield Management, an estimated $48.6M added.

Based on aggregated 13F filings for Q2 2018.